Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Pituitary Neoplasms × Endoscopic Mucosal Resection × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pituitary Neoplasms 1 Esophageal Neoplasms 1 Colorectal Adenoma With Mild Dysplasia 1 Barrett Esophagus 1

Interventions

pasireotide 2 lanreotide 1 Rosiglitazone 1 Pafolacianine 1 Endoscopic Mucosal Resection 1 Dexamethasone 1 Calcium Dobesilate 1 Cabergoline 1 2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03515603 2023-05-17

Endocrine Outcome of Surgery for Pituitary Adenoma

University of Ulm

Phase NA Terminated

Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡